Stay updated with breaking news from கைலி ஓக்கீபே. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) News provided by Share this article Share this article SOUTH PLAINFIELD, N.J., April 19, 2021 /PRNewswire/ PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on April 13, 2021 it approved non-statutory stock options to purchase an aggregate of 75,085 shares of its common stock and 33,740 restricted stock units ( RSUs ), each representing the right to receive one share of its common stock upon vesting, to 79 new employees. The awards were made pursuant to the NASDAQ inducement grant exception as a component of the new hires employment compensation. The inducement grants were approved by PTC s Compensation Committee on April 13, 2021 and are being made as an inducement material to each employee s acceptance of employment with the Company in accordance with NASDAQ Listing Rule 5635(c)(4). ....
Continued Improvements in Motor Milestones in Infants with Type 1 Spinal Muscular Atrophy After Two Years of Treatment with Evrysdi™ - Evrysdi increased survival and reduced need for permanent ventilation - News provided by Share this article Share this article SOUTH PLAINFIELD, N.J., April 15, 2021 /PRNewswire/ PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that results from Part 2 of the pivotal FIREFISH trial demonstrated that infants with type 1 spinal muscular atrophy (SMA) treated with Evrysdi™ (risdiplam) obtained increases in survival and sustained improvements in achieving key motor milestones, including head control, sitting, rolling over, and further developing towards acquiring the ability to stand, and walk. Data were presented at the 2021 American Academy of Neurology (AAN) Virtual Annual Meeting. ....
Continued Improvements in Motor Milestones in Infants with Type 1 Spinal Muscular Atrophy After Two Years of Treatment with Evrysdi™ prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article Share this article SOUTH PLAINFIELD, N.J., April 14, 2021 /PRNewswire/ PTC Therapeutics, Inc. (NASDAQ: PTCT) today introduced a new no-charge, patient-initiated testing program in the United States for individuals who have symptoms consistent with, or a diagnosis of, cerebral palsy (CP) with no evidence of brain injury. CP is a group of disorders that affect a person s ability to move and maintain balance and posture. Many of the common symptoms of CP are similar to other neurotransmitter disorders, such as Aromatic L-amino Acid Decarboxylase (AADC) deficiency, resulting in potential misdiagnosis. The program, PTC Pinpoint Direct™-CP Spectrum, is an innovative, genetic testing program which includes expert genetic counseling at no charge for eligible patients. ....
PTC Therapeutics Received Gallup’s “Don Clifton Strengths-Based Culture” Award SOUTH PLAINFIELD, N.J., April 7, 2021 / PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it has been named a winner of the 2021 “Don Clifton Strengths-Based Culture Award” from Gallup. The award recognizes organizations with strong workplace cultures that get the best out of their employees by focusing and developing their strengths and placing them at the center of how they work every day.
“We are honored to accept this award and appreciate the recognition that at PTC we have built an engaging and innovative work environment that is collaborative and committed to develop our employees,” said Stuart W. Peltz, Ph.D., Chief Executive Officer of PTC Therapeutics. “While the past year has presented many challenges due to the COVID-19 pandemic, our team has proven that we can work smarter and go farther together. At PTC we say that science is our foundation ....